University of Vermont

College of Medicine

Department of Medicine

Gastroenterology & Hepatology

This page has moved to here!

Gastroenterology and Hepatology University of Vermont College of Medicine
Dr. Ferrentino & team

Academic and Clinical Excellence

Our Gastroenterology & Hepatology unit brings together a team of exceptionally talented physicians and bioscience investigators to provide advanced solutions to disorders of the digestive tract (esophagus, stomach, and intestines), pancreas, and liver.

Our major missions are to generate advances in the diagnosis and treatment of these disorders, to train the next generation of experts in digestive diseases, and to optimize the digestive health of patients in Vermont, upstate New York and beyond.

Research & Education

Our faculty combines basic, clinical and translational research expertise to tackle critical issues in digestive disorders. Major areas of focus include inflammatory bowel disease, gastro-intestinal malignancy, and viral hepatitis.

Our fellowship program incorporates in-depth clinical training, research, and scholarly activities. Faculty members teach medical students fundamentals in gastrointestinal pathobiology in the Vermont Integrated Curriculum, while senior medical students and medical residents learn about digestive diseases through a structured one-month elective rotation.

Patient Care

As the largest gastrointestinal specialty group in Vermont and northeast New York, we are a major referral center for diverse and complex digestive disorders in the region.

Dr. Richard Zubarik

Faculty Showcase Richard Zubarik, M.D.

Dr. Zubarik, Steven Lidofsky, M.D., Ph.D., James Vecchio M.D., and collaborators from Dartmouth Medical School tested a new method for detecting pancreatic cancer at a curable stage. In this study, published in Gastrointestinal Endscopy, Zubarik and colleagues demonstrated that in healthy individuals with a family history of pancreatic cancer, combining a simple blood test for the tumor marker CA19-9 with endoscopic ultrasound (in individuals with elevated CA19-9 levels) permitted the detection of unsuspected small tumors that were in a curative stage. Dr. Zubarik's work opens up new avenues for the diagnosis of pancreatic cancer and prolonging survival in this disease.

Last modified November 01 2016 02:40 PM